Skip to main content
Premium Trial:

Request an Annual Quote

Expanded Testing in UK

Community COVID-19 testing is to be expanded in Bristol and Liverpool as part of a push to stop the spread of new viral variants, the Guardian reports.

Viral variants have been identified in the UK, South Africa, and Brazil. Initial studies have suggested that the UK variant may be more easily transmitted, while others have indicated that existing vaccines may be less effective against the South African one. 

UK Health Minister Matt Hancock announced the expanded testing earlier this week, the Guardian says, adding that Hancock noted that 11 cases of "mutations of concern" had been identified in Bristol and 32 in Liverpool. It notes, though, that Public Health England later determined that cases did not represent South African and Brazilian viral strains, but original SARS-CoV-2 pandemic or UK strains that also developed a mutation — E484K — seen in those strains. 

"As with the variant first identified here in the UK, there is currently no evidence to suggest it is any more severe but we have to come down on it hard," Hancock told MPs, according to the Guardian. "Our mission must be to stop its spread all together and break those chains of transmission."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.